Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists
- 10 February 1995
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 56 (11-12) , 861-868
- https://doi.org/10.1016/0024-3205(94)00021-j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anti-HCV seroprevalence in pregnant women in France.Gut, 1993
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Muscarinic receptor subtypes in airwaysLife Sciences, 1993
- Painful irritable bowel syndrome and sigmoid contractionsClinical Radiology, 1991
- Oxybutynin Hydrochloride (3 mg) in the Treatment of Women with Idiopathic Detrusor InstabilityBritish Journal of Urology, 1990
- The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitroBritish Journal of Pharmacology, 1990
- Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferensEuropean Journal of Pharmacology, 1988
- Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndromeEuropean Journal of Clinical Pharmacology, 1988
- Altered small bowel motility in irritable bowel syndrome is correlated with symptomsGastroenterology, 1987
- Colonic Myoelectrical Activity in Irritable-Bowel SyndromeNew England Journal of Medicine, 1978